CG
DWTX

Cutler Group’s Dogwood Therapeutics DWTX Stock Holding History

Cutler Group’s Portfolio DWTX Stock Details DWTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		$1K Hold
92
– – ﹤0.01% 2152
2023
Q4 		$1K Hold
92
– – ﹤0.01% 3515
2023
Q3 		$2K Hold
92
– – ﹤0.01% 3384
2023
Q2 		$3K Hold
92
– – ﹤0.01% 2931
2023
Q1 		$0 Hold
92
– – ﹤0.01% 4880
2022
Q4 		$0 Buy
92
+44
+92% +$331 ﹤0.01% 5391
2022
Q3 		$0 Buy
+48
New +$6.76K ﹤0.01% 5646

Other funds holding DWTX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
MCG
McCollum Christoferson Group Amherst, New York $341M AUM 15.01% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
RFC
Regions Financial Corp Birmingham, Alabama $15.4B AUM 21.7% 1-Year Est. Return
Northwestern Mutual Wealth Management
Northwestern Mutual Wealth Management Milwaukee, Wisconsin $162B AUM 16.35% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Cutler Group's DWTX Position: Q1 2024 in Review

Cutler Group held its Dogwood Therapeutics (DWTX) position steady in Q1 2024 at 92 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #2152.

Cutler Group first reported a position in DWTX in Q3 2022 and has held it in 7 quarters since. The position peaked at $3K in Q2 2023. 21 funds tracked by Wall St. Rank hold DWTX as of Q1 2024.

  • Cutler Group held 92 shares of Dogwood Therapeutics worth $1K as of Q1 2024.
  • Cutler Group left its Dogwood Therapeutics share count unchanged in Q1 2024.
  • Dogwood Therapeutics made up ﹤0.01% of Cutler Group's portfolio in Q1 2024, its #2152 holding.
  • Cutler Group first reported a position in Dogwood Therapeutics in Q3 2022 and has held it in 7 quarters since.
  • Cutler Group's Dogwood Therapeutics position peaked at $3K in Q2 2023.
  • 21 funds tracked by Wall St. Rank held Dogwood Therapeutics as of Q1 2024.

Based on Cutler Group's 13F filing for Q1 2024, filed 19 Apr 2024.